Results 21 to 30 of about 28,626 (269)

Long-term outcomes of omniflow II biosynthetic vascular graft in lower extremity arterial revascularization [PDF]

open access: yes, 2018
Background: This study aims to evaluate the patency rates and long-term outcomes of femoro-popliteal bypass procedures with Omniflow II biosynthetic vascular grafts in patients with occlusive vascular disease.
Göncü, M.T.   +4 more
core   +1 more source

Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]

open access: yes, 2006
Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger   +5 more
core   +2 more sources

Bridge saphenous vein graft

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1975
Single aorta-coronary artery vein grafts (bridge grafts) were constructed to two coronary branches with a side-to-side anastomosis in 250 patients. Most of these grafts were constructed between circumflex branches (96 grafts), circumflex and diagnol branches (47 grafts), and anterior descending and diagonol branches (79 grafts).
C, Cheanvechai   +6 more
openaire   +2 more sources

“Water running in my chest”: Delayed spontaneous rupture of an aortocoronary saphenous vein graft aneurysm

open access: yesClinical Case Reports, 2021
Saphenous vein graft aneurysm is an uncommon condition and knowledge about its natural history, and a multi‐specialty heart team approach is of utmost importance for better clinical outcomes.
Eric Gnall   +5 more
doaj   +1 more source

Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile [PDF]

open access: yes, 2013
<p>Background: Cardiovascular disorders, including coronary artery bypass graft failure and in-stent restenosis remain significant opportunities for the advancement of novel therapeutics that target neointimal hyperplasia, a characteristic of both ...
AA Soyombo   +47 more
core   +2 more sources

Saphenous Vein Graft Pseudoaneurysm

open access: yesJournal of the American College of Cardiology, 2009
![Figure][1] [![Graphic][3] ][3][![Graphic][4] ][4] A 71-year-old man with a history of coronary artery bypass grafting 10 years earlier presented with recurrent angina. A repeat coronary angiogram revealed a large pseudoaneurysm in the saphenous vein graft supplying the ...
Rahim, Sherali A.   +2 more
openaire   +2 more sources

Ruptured saphenous vein graft aneurysm [PDF]

open access: yesEuropean Journal of Cardio-Thoracic Surgery, 2013
Ruptured saphenous vein graft (SVG) aneurysm is a rare source of significant morbidity and mortality. SVG is a common technique of coronary artery bypass grafting (CABG), but vein graft aneurysm and ruptured SVG aneurysm have not received the required attention as only few case reports exist.
Philemon, Gukop   +2 more
openaire   +2 more sources

Hemodynamic study on upper extremity: simulation on straight reverse saphenous vein graft [PDF]

open access: yes, 2012
Artery reconstruction in upper extremities is rare performed compare to the incidence of reconstruction in lower extremities. In many cases, primary vascular repair was performed, whenever, otherwise, the interposition vein graft or venous bypass ...
A. H., Khairul   +6 more
core   +1 more source

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent

open access: yesCase Reports in Cardiology, 2021
Saphenous vein graft aneurysms (SVGAs) occur as a rare complication of coronary artery bypass graft but increases the risk of morbidity and mortality. Atherosclerosis is considered to be the most common cause of saphenous vein graft aneurysms.
Kyriacos Papadopoulos   +1 more
doaj   +1 more source

Gene Therapy for Cardiovascular Disease [PDF]

open access: yes, 2003
The last decade has seen substantial advances in the development of gene therapy strategies and vector technology for the treatment of a diverse number of diseases, with a view to translating the successes observed in animal models into the clinic ...
Baker, Andrew H.   +3 more
core   +4 more sources

Home - About - Disclaimer - Privacy